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Introduction
Lung cancer is the most common cause of cancer-related death worldwide [1] . Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases. Therefore, the identification of methods to improve the survival rate of patients with NSCLC has become an important task [2] . At present, treatment for NSCLC includes surgery, chemotherapy, and radiotherapy [3] , of which radiotherapy is the main approach [4] . Nevertheless, despite the great efforts that have been exerted to develop radiation therapies for NSCLC patients, the 5-year overall survival rate still remains less than 15% [1, 5] . Local recurrence is a common clinical problem and is the primary contributor to the poor prognosis of a large number of patients [6] . One of the major reasons for local recurrence is the development of radiation resistance [7] . Therefore, clarification of the mechanism underlying radiation resistance and the establishment of a valid prognostic factor and therapeutic target are clinically important.
MicroRNAs (miRNAs) are a class of small, single-stranded, endogenous non-coding RNA consisting of 19-25 nucleotides [8] . miRNAs interact with the 3′-untranslated region (UTR) of the mRNA of target genes to promote mRNA degradation and/or inhibit protein translation [9] . With the expansion of efforts to study miRNA expression, abnormal expression patterns of miRNAs have been identified as unique clinical biomarkers that are relevant for diagnosis, stage, prognosis, and response to treatment [10] . Additionally, miRNAs can also regulate radiation sensitivity by activating oncogenic pathways or suppressing tumor suppressor gene pathways or protein expression [11] . Differences in miRNA expression are associated with the efficacy of radiotherapy and may act as biomarkers for predicting the efficacy of radiotherapy [12] . Furthermore, miRNA (miR)-99a has been identified as an important prognostic factor that regulates radiation sensitivity in a variety of different cancers, such as renal cancer and prostate cancer [13] [14] [15] . With regard to NSCLC, miR-99a expression is upregulated in lung cancer tissues as compared with matched normal tissues [16, 17] . These results suggest that miR-99a might play a critical role in NSCLC radiation sensitivity, but the underlying mechanism remains unknown.
Mammalian target of rapamycin (mTOR), as a downstream gene of the PI3K/AKT pathway, has been a hot target for cancer research in recent years [18] . This pathway has been implicated in the regulation of angiogenesis, cell survival, proliferation, and metastasis [19] . Furthermore, mTOR also plays an important role in radiation sensitivity, and an inhibitor of mTOR has been shown to enhance radiosensitivity [20] [21] [22] . However, the detail mechanisms remain poorly defined.
In this study, we found that miR-99a was significantly upregulated in radiationsensitive A549 cells compared with radiation-resistant A549 cells. Specifically, miR-99a overexpression enhanced radiosensitivity and apoptosis by directly targeting mTOR in vitro and in vivo. According to our results, we propose that miR-99a is a potential miRNA for modulating the radiation sensitivity of NSCLC.
Materials and Methods
To analyze the expression of miR-99a and mTOR in NSCLC, we used the datasets in TCGA (https:// cancergenome.nih.gov). We queried TCGA for miR-99a and mTOR gene and filtered the results by selecting NSCLC and the Lung Cancer vs. Normal Analysis database. The results were displayed using a box chart, and Student's t-test was used to calculate P-values.
Cell culture
The normal lung epithelial cell line HBE and NSCLC cell lines A549, H1650, and H1299 were obtained from Heilongjiang Cancer Institute (Harbin, China). The cells were cultured in RPMI-1640 supplemented with 10% fetal bovine serum at 37°C with 5% CO 2 .
To generate radiation-resistant cells, A549 cells were firstly grown to approximately 90% confluence and then exposed to irradiation at 2.0 Gy/fraction using 6 MV X-rays generated by an accelerator provided by Harbin Medical University Cancer Hospital, and the final dose was 64 Gy. The selected radioresistant cell line was named A549-R.
Real-time quantitative PCR (qPCR)
RNA from cells and tissues was isolated using the TRIzol reagent (Invitrogen). The isolated RNA was then reverse transcribed into cDNA using a cDNA Synthesis Kit (Fermentas, Foster City, CA, USA). Levels of miR-99a and U6 expression were determined using a SYBR Premix Ex-Taq II Kit and an ABI 7500 machine according to the manufacturer's instructions. The 2 -ΔΔCt method was used to calculate expression levels.
Western blot analysis
The cells were lysed in a lysis buffer, and 50 μg protein from each sample was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% gels) and transferred to a polyvinylidene fluoride membrane. The membrane was probed with anti-mTOR, anti-phosphorylated (p)-mTOR, anti-Bcl-2, anticyclin D1, anti-p-Smad3, anti-p-S6, and anti-S6 antibodies (Cell Signaling). Antibody detection was performed using an ECL Western Blotting Detection System. Band intensities were normalized to the glyceraldehyde 3-phosphate dehydrogenase loading control.
Plasmid transfection
The miR-99a mimics, miR-99a inhibitor, mTOR plasmid, and controls were purchased from Santa Cruz Biotechnology. Lipofectamine 2000 (Invitrogen) was used according to the manufacturer's instructions. The transfected cells were collected for analyses at 24 h after transfection.
Dual luciferase reporter assay
We seeded 1.0 × 10 5 H1299 cells/well in a 24-well plate. Transcriptional activity was detected by cotransfection of mTOR-3′-UTR-wild-type or mTOR-3′-UTR-mutant and miR-99a or miR-negative control (NC) using Lipofectamine 2000 (Invitrogen) as per the manufacturer's instructions. Luciferase activity was assayed at 24 h post-transfection using the Dual Luciferase Reporter Assay System (Promega) and normalized to Renilla luciferase activity.
Colony formation assay
The cells were plated at a low density in 6-well plates overnight. The cells were then irradiated with 0, 2, 4, 6, 8, or 10 Gy X-rays and then incubated for 14 days. After fixation with methanol, the cells were stained with crystal violet and counted. All experiments were conducted at least three times. Survival rates were evaluated relative to 0 Gy radiation-treated controls. A single-hit multi-target model was used to analyze the data. A survival curve was plotted for each group as the log of the survival fraction versus radiation dose using GraphPad Prism 5.0 software.
Flow cytometry
The cells were irradiated with 6 Gy X-rays after transfection with miR-99a mimics, inhibitor, or NC. For the analysis of apoptosis, the collected cells were pooled and stained with 5 μL annexin V-FITC and 10 μL propidium iodide (PI) using an Annexin V FITC Apoptosis Detection Kit I (556547; BD Biosciences) according to the manufacturer's instructions and analyzed on a BD Accuri C6. For cell cycle analysis, the cells were washed with cold phosphate-buffered saline (PBS) and fixed with 70% ethanol overnight at -20°C. The fixed cells were washed with PBS for 10 min and processed for PI/RNase staining. The cell cycle stage of each sample was evaluated by flow cytometry (Becton-Dickinson). 
Immunohistochemistry
Tissue sections were immersed in minocycline-ethylenediaminetetraacetic acid, heated in a steamer at 100°C for 15 min, and incubated in methanol for 15 min. The slides were incubated with an anti-mTOR primary antibody, stained using 3, 3′-diaminobenzidine, and counterstained with hematoxylin. Relative staining intensity was judged according to the percentage of immunoreactive cells.
In vivo radiation sensitivity
The animal experiments were approved by the Scientific Investigation Board of the Tumor Hospital of Harbin Medical University. We purchased 4-6-week-old nude mice (male) from the Shanghai Experimental Animal Center, and they were bred in the Animal Center of the affiliated Tumor Hospital of Harbin Medical University. The mice were injected with 4.0 × 10 6 A549 cells. After 8 days, the transplanted nude mice were randomly divided into two groups. Agomir-miR-99a or agomir-NC (RiboBio Co., Ltd., Guangzhou, China) was injected directly into the implanted tumor at a dose of 1 nmol per mouse every 4 days for a total of 7 times. Tumor volume (V) was calculated with the equation: V = (W 2 × L) × 0.5. When the volume of tumors reached 500 to 1000 mm 3 (at approximately 20 days after injection), the mice were exposed to 10 Gy X-rays once every 3 days for a total of 2 exposures: applicator size, 15 × 15 cm; final radiation field for the tumor was 1 cm greater than the edge of the tumor with lead block shielding, covering a 1 cm bolus on the surface of the tumor to enhance the subcutaneous radiation dose; source to skin distance, 100 cm; and electron beam irradiation, 9 MeV. Seven weeks later, the mice were sacrificed and the tumors and lungs were harvested and fixed in formalin.
Statistical analysis SPSS 18.0 and GraphPad Prism software were used for statistical analyses. Statistical significance between two groups was calculated by Student's t-test. Statistical significance is indicated using asterisks: *P < 0.05 and **P < 0.01.
Results

miR-99a
expression is significantly downregulated in human lung cancer tissues To determine the role of miR-99a in NSCLC development, we analyzed miRNA and gene expression profiles using 999 NSCLC samples and 91 adjacent normal lung tissues obtained from the TCGA database. miR99a was found to be significantly downregulated in NSCLC tissues compared with adjacent normal 
lung tissues (P < 0.05, Fig. 1A) . Furthermore, NSCLC patients with high miR-99a expression had better overall survival than those with low miR-99a expression (P < 0.05, Fig. 1D ).
miR-99a sensitizes NSCLC cells to radiation therapy
To explore the role of miR-99a, we analyzed the expression levels of miR-99a in HBE normal lung epithelial cells, H1650 cells, and A549 cells. qPCR analysis showed that miR-99a expression was significantly lower in H1650 and A549 cells than in HBE cells ( Fig. 2A) .
Then, we generated a radiation-resistant NSCLC cell line to investigate the association between miR-99a expression and radiation sensitivity. miR-99a expression levels were significantly downregulated in the A549-R cells compared with the A549 cells ( Fig. 2A) . Thus, these results suggested that miR-99a may contribute to radiation resistance in NSCLC cells.
Following this analysis, to assess further the role of miR-99a in the radiation sensitivity of NSCLC cells, A549 cells were transfected with miR-NC and miR-99a inhibitors. By contrast, A549-R cells were transfected with miR-NC and miR-99a-mimics, and the expression levels of miR-99a were verified by qPCR (Fig. 2B) . In addition, A549, A549-R, and transfected cells were exposed to various doses of radiation (0, 2, 4, 6, 8, or 10 Gy), and we found that miR99a enhanced the effect of radiation in A549-R cells and reduced its effect in A549 cells ( Fig.  2C and D) . These results further suggested that the upregulated expression of miR-99a may enhance radiation sensitivity. Radiation sensitivity is often related to cell cycle arrest and apoptosis; therefore, we used flow cytometry analysis to study the effect of miR-99a on apoptosis and the cell cycle in irradiated NSCLC cells. Cells transfected with the miR-99a mimics showed a higher percentage of cells in the G1 stage than the miR-NC and untreated groups of A549-R cells (P < 0.05) and a lower percentage of cells in the S stage (P < 0.05, Fig. 2E ). By contrast, the percentage of anti-miR-99a-A549 cells in the G1 phase was decreased and the percentage of these cells in the S phase was increased compared with the anti-NC and untreated groups (P < 0.05, Fig. 2E ). Analysis of apoptosis showed that miR-99a combined with irradiation increased the ratio of apoptotic A549-R cells (P < 0.05, Fig. 2F ). However, blocking miR99a combined with irradiation significantly decreased the ratio of apoptotic A549 cells (P < 0.05, Fig. 2F ). Therefore, these data suggested that miR-99a could increase the radiation sensitivity of NSCLC cells, which may have been caused by the induction of cell arrest in the G1 phase and increased apoptosis when miR-99a was combined with radiation treatment.
mTOR is a direct target of miR-99a
To explore the mechanisms underlying the effects of miR-99a on cell proliferation and radiation sensitivity in NSCLC, potential target genes were analyzed by using four bioinformatics approaches: miRanda, PITA, TargetScan, and miRWalk. All four approaches localized mTOR at the center of a net comprising 86 genes (Fig. 3A) and predicted that miR99a may target the 3′-UTR region of mTOR.
Next, we searched the TCGA database again and found that mTOR expression was upregulated in NSCLC tissues compared with normal lung tissues (P < 0.01, Fig. 1B) . Additionally, for TCGA NSCLC patients, miR-99a expression was inversely correlated with mTOR levels, and mTOR expression was correlated with survival (P < 0.05, Fig. 1C and E) .
To confirm our speculation further, we generated luciferase reporters for miR-99a and mTOR. H1299 cells were transfected with wild-type or mutant mTOR. miR-99a was found to significantly decrease luciferase activity in cells transfected with wild-type mTOR 3′-UTR (P < 0.05), while no significant effect was observed in cells transfected with mutant mTOR 3′-UTR (Fig. 3B) . 
Cellular Physiology
In addition, we detected the protein and mRNA levels of mTOR and components of its downstream pathway, including p-mTOR and p-S6. The levels of mTOR were found to be significantly decreased in A549 cells compared with A549-R cells. After transfection with miR-99a mimics, the levels of mTOR, p-mTOR, and p-S6 were decreased in A549-R cells. By contrast, after transfection with miR-99a inhibitors, the levels of mTOR, p-mTOR, and p-S6 were increased in A549 cells (Fig. 3C) . Therefore, these results showed that mTOR was a target of miR-99a, as predicted.
mTOR plays a crucial role in the miR99a-mediated r a d i a t i o n sensitivity
of NSCLC cell lines W e i n v e s t i g a t e d whether mTOR was responsible for the radiation sensitivity of NSCLC cells regulated by miR99a. When mTOR was inhibited in anti-miR-99a-A549 cells by AZD2014, the cells became more sensitive to radiation than control cells (Fig. 4A ) and the levels of anti-apoptosis markers were reduced (Fig. 4D) . When mTOR was transfected into miR-99a-A549-R cells, the cells became more resistant to radiation therapy than control cells and the expression of antiapoptosis markers was increased ( Fig. 4A-D) .
miR-99a regulates radiosensitivity in vivo
To analyze whether miR-99a could influence NSCLC radiosensitivity in vivo, we used an NSCLC mouse model. miR-99a combined with irradiation was observed to significantly decrease tumor volume compared with the miR-NC group (Fig. 5A , B, and C). Furthermore, immunohistochemical analysis indicated that mTOR expression was decreased in the miR99a agomir group compared with the NC group (Fig. 5D ). These in vivo findings further proved that miR-99a enhanced the radiation sensitivity of NSCLC by targeting mTOR.
Discussion
Radiation therapy is known to be an important approach for the treatment of NSCLC, but the obstacle of radiation resistance has a negative effect on the survival of patients with NSCLC [23] . Recently, several studies have suggested that miRNAs play a role in the radiation resistance of NSCLC by interacting with tumor-related genes [24, 25] . Hence, it is important to characterize tumor-related miRNAs and their tumor-relevant gene targets [26] . Furthermore, by exploring the biological significance of these genes, we can identify novel therapeutic targets for enhancing the efficacy of radiation therapy and improve the survival of these patients.
miR-99a has been reported to be abnormally expressed in various malignant tumors and may function as a tumor suppressor. For example, downregulation of miR-99a in oral squamous cell carcinoma contributes to the growth and survival of oral cancer cells [27] . In osteosarcoma and hepatocellular cancer, miR-99a also functions as a tumor suppressor [28, 29] . In the present study, miR-99a expression was significantly downregulated in human lung cancer tissues compared with adjacent normal lung tissue and was correlated with survival, which was similar to the observations of the previous studies.
Furthermore, miR-99a has been shown to be correlated with not only tumor proliferation but also radiation sensitivity. For example, miR-99a enhances the radiosensitivity of prostate cancer cells and rectal carcinoma [14, 15] . However, whether the differential expression of miR-99a in malignant and benign NSCLC lesions can regulate radiosensitivity is still in question. Therefore, we examined differences in the expression of miRNAs in radiationsensitive and radiation-resistant NSCLC cells and found that miR-99a was overexpressed in radiation-sensitive cells. Our study also showed that miR-99a influenced the radiosensitivity of NSCLC, and specifically, miR-99a overexpression increased radiosensitivity and the rate of apoptosis. By contrast, downregulating miR-99a expression resulted in radiation resistance. mTOR is located downstream of the PI3K/AKT pathway and could regulate radiosensitivity by having an impact on the cell cycle and apoptosis. AZD2014 is an inhibitor of mTOR and has been shown to enhance radiation sensitivity, apoptosis, and DNA damage, and to suppress proliferation and clonogenicity [30, 31] . For example, this inhibitor of the mTOR pathway enhanced the radiosensitivity of prostate cancer and glioma stem cells [32, 33] . Consistent with the role of mTOR observed in previous studies, we found that AZD2014 enhanced cellular sensitivity to radiation; by contrast, upregulating mTOR expression decreased radiation sensitivity. Furthermore, by bioinformatics software and luciferase experiments, we demonstrated that mTOR is a direct target of miR-99a, and inhibition of mTOR generated similar effects as that of ectopic miR-99a expression, whereas mTOR overexpression rescued the function of miR-99a-mediated radiosensitivity in NSCLC cells.
Radiosensitivity is affected by a complex signaling cascade and a variety of responses that include cell cycle arrest, induction of stress-response genes, DNA repair, and apoptosis [34] . In the present study, some important functional alterations in genes were observed, including Bcl-2 and cyclin D1, which are related to anti-apoptosis and the cell cycle, during miR-99a-mediated mTOR inactivation. Especially, mTOR inhibition by AZD2014 displays a consentaneous phenomenon with the effect of miR-99a. These data support the major involvement of miR-99a-mediated mTOR inactivation and increased radiosensitivity in the induction of apoptosis.
In summary, our study demonstrated that miR-99a augmented the radiosensitivity of NSCLC cells in vitro and in vivo. Furthermore, miR-99a may increase the radiosensitivity of NSCLC cells by directly targeting the mTOR signaling pathway. miR-99a and mTOR expression was negatively correlated and associated with radiosensitivity. Thus, miR-99a plays multiple tumor-suppressive roles in NSCLC cells. Our findings suggest that miR-99a and mTOR might be promising prognostic and therapeutic targets to increase radiosensitivity in NSCLC.
